Mustang Share Price
NASDAQ: MBIO | Healthcare$0.00
-$0.37 (--%) Mustang Stock Performance
Mustang Share Price Chart
$0.00$0.00
L
H
Mustang Quarterly Profit & Loss
All figures in USD
Mustang Annual Profit & Loss
All figures in USD
Mustang Balance Sheet
All figures in USD Million
Mustang Cash Flow
Annually
All figures in USD Million
Corporate Actions
About Mustang
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Mustang Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.41 | $0.37 | -13.15% |
Oct 2026 | $0.46 | $0.43 | -18.39% |
Sep 2026 | $0.55 | $0.52 | -6.79% |
Aug 2026 | $0.57 | $0.56 | -5.08% |
Jul 2026 | $0.70 | $0.59 | -15.11% |
Jun 2026 | $0.73 | $0.69 | +4.67% |
May 2026 | $0.75 | $0.66 | -10.39% |
Apr 2026 | $0.73 | $0.74 | +1.09% |
Mar 2026 | $0.91 | $0.73 | -28.14% |
Feb 2026 | $0.98 | $1.02 | +2.31% |
Jan 2026 | $1.05 | $1.00 | +1.22% |
Dec 2025 | $1.36 | $0.98 | -30.14% |